← Back to All Filings

Hologic COO Awarded 9,116 Shares in Stock Grant ($HOLX)

Low SignificanceNovember 6, 2025 at 4:34:10 PM EST

HOLOGIC INC

$HOLX4CIK: 0000859737

Subscribe to track HOLX

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Hologic COO Awarded Stock Grant ($HOLX)

Company: HOLOGIC INC (HOLX) Form: 4 | Filed: 2025-11-06 Significance: Low

Insider: Mitchell Essex D Title: Chief Operating Officer | Relationship: Officer

Transaction: • Type: Grant • Shares: 9,116 • Price: $0.00 • Value: $0 • Owned After: 37,474

Key Insight: This is a routine grant of performance stock units as part of executive compensation, representing a negligible 0.004% of shares outstanding.

Market Context: The grant increases the COO's direct holdings, aligning interests with shareholders, but is not a market-moving event for a company with a $16.49B market cap.

View Full Filing

Comprehensive Analysis

SEC Filing Analysis: HOLOGIC INC (HOLX)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The Chief Operating Officer of Hologic was awarded 9,116 performance stock units as part of a standard executive compensation plan.
  • Market Impact: Neutral. The transaction is a routine grant and has no material impact on the company's financials or stock dilution.

Company Information

FieldValue
CompanyHOLOGIC INC
Ticker SymbolHOLX
CIK0000859737
IndustryX-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS

Insider Information

FieldValue
NameMitchell Essex D
CIK0001951176
Title/PositionChief Operating Officer
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-11-04
Transaction CodeA (Grant)
Security TypeCommon Stock
Shares Involved9,116
Price Per Share$0.00
Total Value$0
Shares Owned After37,474
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0
% of Market Cap0.0%
Shares Transacted9,116
% of Shares Outstanding0.004%
Post-Transaction Ownership37,474 shares (0.017% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The transaction has a value of $0 and involves a number of shares that is insignificant relative to Hologic's $16.49 billion market capitalization.
  • Dilution Impact: The issuance of 9,116 shares represents a negligible 0.004% of the total shares outstanding, posing no meaningful dilution risk to existing shareholders.
  • Transaction Significance: This is a routine award of performance stock units, a common form of non-cash compensation for executives. It is not an open-market transaction and carries low significance for investors.

Additional Context

Transaction Notes

  • Footnote F1: The filing notes these are performance stock units where performance criteria have been met, but they remain subject to service-based vesting.
  • Footnote F2: The units settle on a one-for-one basis for common stock, hence the $0 price.
Topics:#SECFiling#InsiderTrading#Hologic#HOLX#Form4#StockGrant#ExecutiveComp#MarketAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.